The global albumin market was valued at $5.4 billion in 2022, and is projected to reach $9.9 billion by 2032, growing at a CAGR of 6.2% from 2023 to 2032.
The Vietnam plasma fractionation market was valued at $56.62 million in 2019, and is expected to reach $79.03 million by 2027, registering a CAGR of 5.3% from 2020 to 2027.